MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Impact of subthalamic deep brain stimulation on sensorimotor and motor cortical oscillatory activity in free-moving hemiparkinsonian rats

    A. Abdulbaki, T. Doll, J. Krauss, M. Alam, K. Schwabe (Hannover, Germany)

    Objective: The effect of STN DBS on the spectral power of oscillatory activity in the classic frequency bands in the motor cortex (MCtx) and sensorimotor…
  • 2019 International Congress

    Investigation into the causes of reduced caffeine levels in Parkinson’s disease

    MI. de Bartolo, G. Leodori, A. Fabbrini, M. Costanzo, D. Belvisi, A. Conte, S. Manetto, A. Ciogli, C. Villani, A. Berardelli, G. Fabbrini (Rome, Italy)

    Objective: To find out whether PD patients show decreased salivary caffeine levels; to investigate CYP1A2-phenotype and caffeine absorption as possible causes of decreased caffeine levels…
  • 2019 International Congress

    Certification of cause of death in patients with Parkinson’s Disease (PD)

    M. Khwaja, A. Chatterjee (Reading, United Kingdom)

    Objective: To evaluate the accuracy of death certification in patients with PD. Background: The National Statistics Office guidance (1) suggests that doctors completing Medical Certificate…
  • 2019 International Congress

    CSF levels of NFL (neurofilament light chain) in Parkinsons’ disease patients

    E. Papuć, K. Rejdak (Lublin, Poland)

    Objective: The aim of this study was to assess cerebro-spinal fluid (csf) NFL levels  in PD patients and healthy controls subjects. Background: Neurofilament light chain…
  • 2019 International Congress

    Does information from the Personal KinetiGraph™ (PKG) influence neurologists´ treatment decisions?

    M. Sundgren, P. Rousu, A. Johansson (Stockholm, Sweden)

    Objective: To evaluate if PKG data influences neurologists´ treatment decisions in routine clinical care of patients with Parkinson´s disease. Background: The PKG movement recording system is…
  • 2019 International Congress

    Application of the Movement Disorders Society Criteria for diagnosis of Progressive Supranuclear Palsy

    F. Ali, H. Botha, E. Ahlskog, J. Bower, A. Hassan, D. Dickson, J. Whitwell, K. Josephs (Rochester, MN, USA)

    Objective: Analyze the sensitivity, specificity of the Movement Disorders Society (MDS) criteria for progressive supranuclear palsy (PSP) and apply the multiple allocation extinction (MAX) rules…
  • 2019 International Congress

    Limitations of Curcumin as a Therapeutic Agent in Rotenone Induced Dopaminergic Neurodegeneration: Insights from Drosophila Model of Parkinson’s Disease

    M. Ayajuddin, SC. Yenisetti (Zunheboto, India)

    Objective: To understand the efficacy of curcumin in rotenone induced Drosophila model of Parkinson’s disease. Background: Parkinson’s disease (PD) is the second most common neurodegenerative…
  • 2019 International Congress

    Medical management after subthalamic nucleus deep brain stimulation in patients with Parkinson’s Disease

    A. Bertholo, R. Cury (São Paulo, Brazil)

    Objective: The present study aims to: i) systematically evaluate literature data on acute medical management after subthalamic nucleus (STN) deep brain stimulation (DBS)  and, ii)…
  • 2019 International Congress

    Safety and Tolerability of opicapone in Parkinson’s disease

    M. Campins Romeu, M. Losada López, I. Sastre Bataller, MJ. Pérez García, I. Martínez Torres (Valencia, Spain)

    Objective: To evaluate safety and tolerability of opicapone as an add‐on treatment to levodopa in Parkinson's disease (PD) patients. Background: Opicapone is a recently approved…
  • 2019 International Congress

    Gender differences of fatigue characteristics in people with Parkinson’s disease

    G. Cilga, T. Kahraman, AC. Kalkan, B. Donmez Colakoglu, A. Genc (Manisa, Turkey)

    Objective: To investigate gender differences in fatigue characteristics in people with Parkinson’s disease. Background: Fatigue is a common problem among people with Parkinson’s disease. It…
  • « Previous Page
  • 1
  • …
  • 117
  • 118
  • 119
  • 120
  • 121
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #25116 (not found)
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley